the aid library

LIST OPTIONS

Filter

7759

A Toolkit for Engaging Non-Health Stakeholders in Supporting Routine Immunization in Uganda

JSI Research & Training Institute; SS4RI (2019) C1

The toolkit presents step-by-step guidance that district health teams (DHTs), district leaders, MOH/UNEPI, immunisation partners, and civil society organisations (CSOs) can use to engage NHS and maximise the benefits of their participation in strengthening RI through activities such as community dia... more

Download (858)

View PDF (936)

Digital Health Toolkit in Medical Education

The EMSA Student Task Force for Digital HealthThe European Medical Student's Association (EMSA)- Association Européenne des Étudiants en Médecine (2020) C1

A Students' Toolkit. How does the digital transformation of health care change the daily routine of a healthcare professional? Which knowledge and skills will healthcare professionals need? Are universities in Europe preparing their students well enough to work within a digitised health system? Th... more

Download (158)

View PDF (266)

SYRIA NEEDS OVERVIEW MARCH 2019

OCHA SYRIA OCHA SYRIA (2019)

The figures and findings reflected in the 2019 Humanitarian Needs Overview (HNO) represent the independent analysis of the United Nations (UN) and its humanitarian partners based on information available to them. While the HNO aims to provide consolidated humanitarian analysis and data to help inf... more

Download (1231)

View PDF (2286)

ORAL REHYDRATION SALTS Production of the new ORS

World Health Organization; UNICEF World Health Organization (WHO) (2006) C_WHO

The document provides detailed guidelines for the production, formulation, and implementation of oral rehydration salts (ORS) to combat dehydration caused by diarrhoea, particularly in children. It focuses on the composition, quality standards, and packaging requirements of ORS, aiming to support na... more

Download (155)

View PDF (168)

Diabetes prevention, screening and management

International Pharmaceutical Federation (2021) CC2

Diabetes is a significant public health issue that affects approximately one in 10 adults globally, with type 2 diabetes accounting for 90–95% of cases. This chronic condition causes considerable morbidity and mortality and is growing in impact, with cases projected to rise from 537 million in 202... more

Download (65)

View PDF (64)

Women and Trachoma: Achieving Gender Equity in the Implementation of SAFE

The Carter Center, International Trachoma Initiative and Kilimanjaro Centre for Community Ophthalmology (2023) CC

The second edition of the Women and Trachoma: Achieving Gender Equity in the Implementation of SAFE manual provides an updated resource for realistically increasing, improving, and supporting gender representation within trachoma elimination efforts at all levels. From the trachoma workforce to the ... more

Download (1223)

View PDF (1976)

Ethical issues in obstetrics and gynaecology by the FIGO committee for the Study of Ethical aspects of Human Reproduction and Woman's Health

FIGO (2012)

'Ethical Issues in Obstetrics and Gynecology' represents the results of carefully researched and considered discussion. The guidelines are intended to provide material for consideration and debate about ethical aspects of our discipline for member organisations and their constituent membership.

Download (411)

View PDF (710)

Living Conditions among People with Disabilities in Lesotho: A National Representative Study

SINTEF Technology and Society Global Health and Welfare (2011) C2

This research report provides results from the study of living conditions among people with disabilities in Lesotho. Comparisons are made between disabled and non-disabled in household level and individual level. Disability was defined as limitation to perform certain activities that was measure... more

Download (250)

View PDF (290)

Keeping the vector out: housing improvements for vector control and sustainable development

Kraef, C.; Röbbel, N. World Health Organization WHO (2017) C_WHO

Vector-borne diseases are responsible for 17% of the global burden of communicable diseases and more than 500 000 deaths annually. The ambitious global targets for the control of vector-borne diseases come in the context of the (re-)emergence of diseases, increasing resistances to insecticides and u... more

Download (266)

View PDF (230)

2019 Antibacterial agents in clinical development: an analysis of the antibacterial clinical development pipeline
recommended

World Health Organization WHO (2019) C_WHO

Of the 50 antibiotics in the pipeline, 32 target WHO priority pathogens but the majority have only limited benefits when compared to existing antibiotics. Two of these are active against the multi-drug resistant Gram-negative bacteria, which are spreading rapidly and require urgent solutions. Gr... more

Download (142)

View PDF (232)

Preliminary Stakeholder Engagement Plan (SEP)

India COVID-19 Emergency Response and Health Systems Preparedness Project (P173836) Ministery of Health and Familiy Welfare - Government of India (2020) C2

A new respiratory infectious disease, COVID-19, caused by a new coronavirus called SARS-CoV-2, emerged in early December 2019. Since then, the virus has spread to India and 106 other countries in Asia, Europe, North America, Africa, and Oceania. On March 11, the World Health Organization (WHO) decl... more

Download (188)

View PDF (249)

Climate change and health: vulnerability and adaptation assessment

World Health Organisation (WHO) (2021) C_WHO

Climate change and health vulnerability and adaptation assessment In 2013 the World Health Organization (WHO) published the report Protecting health from climate change: vulnerability and adaptation assessment. The aim was to provide basic and flexible guidance on conducting national or subnati... more

Download (335)

View PDF (406)

Review on palliative care with focus on 18 high tuberculosis priority countries

World Health Organization WHO, Regional Office of Europe (2021) C_WHO

Tuberculosis (‎TB)‎ is, and should be, a curable disease; however, each year significant numbers of patients acquire or develop drug-resistant TB, which has a much lower cure rate. Patients with drug-resistant TB have a high prevalence of symptoms; hence, staff caring for these patients should h... more

Download (184)

View PDF (221)

Asia Pacific Health Security Action Framework

World Health Organization WHO (2024) C_WHO

Public health emergencies, including pandemics, highlight the need for health systems and services that are prepared, resilient and ready to respond to health security threats. Endorsed by Member States in 2023, the Asia Pacific Health Security Action Framework (‎APHSAF)‎ is designed to engage m... more

Download (52)

View PDF (42)

Malaria elimination programme review india 2022

World Health Organisation (WHO) (2023) C_WHO

The document “Malaria Elimination Programme Review, India 2022”, published by the WHO Country Office for India, provides an in-depth assessment of India’s progress toward malaria elimination. It evaluates the structure, implementation, and effectiveness of national and subnational malaria prog... more

Download (53)

View PDF (35)

Towards Mapping the Fiscal Space: Health Sector Financing Strategy in Mozambique

N’weti, Wemos (2024) CC

This paper was commissioned by N´weti and Wemos as part of the project “Equitable health financing for a strong health system in Mozambique”. Its purpose is to contribute to the debate of the Mozambican Ministry of Health’s draft Health Sector Financing Strategy (HSFS) 2025 – 2034

External Link

China’s hidden role in malaria control and elimination in Africa

Odhiambo J.N., Dolan C., Malik A.A., et al. BMJ Global Health (2023) CC

Insufficient funding is hindering the achievement of malaria elimination targets in Africa, despite the pressing need for increased investment in malaria control. While Western donors attribute their inaction to financial constraints, the global health community has limited knowledge of China’s ex... more

Download (68)

View PDF (39)

Africa’s Health Financing in a New Era

Africa Centres for Disease Control and Prevention (Africa CDC) (2025) CC

Africa’s health sector is facing an unprecedented financing crisis, driven by a sharp decline of 70% in Official Development Assistance (ODA) from 2021 to 2025 and deep-rooted structural vulnerabilities. This collapse is placing immense pressure on Africa’s already fragile health systems as ODA ...is seen as the backbone of critical health programs: pandemic preparedness, maternal and child health services, disease control programs are all at risk, threatening Sustainable Development Goal 3 and Universal Health Coverage. Compounding this is Africa’s spiraling debt, with countries expected to service USD 81 billion by 2025—surpassing anticipated external financing inflows—further eroding fiscal space for health investments. Level of domestic resources is low. TThe Abuja Declaration of 2001, a pivotal commitment made by African Union (AU) member states, aimed to reverse this trend by pledging to allocate at least 15% of national budgets to the health sector. However, more than two decades later, only three countries—Rwanda, Botswana, and Cabo Verde—have consistently met or exceeded this target (WHO, 2023). In contrast, over 30 AU member states remain well below the 10% benchmark, with some allocating as little as 5–7% of their national budgets to health. In addition, only 16 (29%) of African countries currently have updated versions of National Health Development Plan (NHDP) supported by a National Health Financing Plan (NHFP). These two documents play a critical role in driving internal resource mobilisation. At the same time, public health emergencies are surging, rising 41%—from 152 in 2022 to 213 in 2024—exposing severe under-resourcing of health infrastructure and workforce. Recurring outbreaks (Mpox, Ebola, cholera, measles, Marburg…) alongside effects of climate change and humanitarian crises in Eastern DRC, the Sahel, and Sudan, are overwhelming systems stretched by chronic underfunding. The situation is worsened by Africa’s heavy dependency with over 90% of vaccines, medicines, and diagnostics being externally sourced—leaving countries vulnerable to global supply chain shocks. Health worker shortages persist, with only 2.3 professionals per 1,000 people (below the WHO’s recommended 4.45), and fewer than 30% of systems are digitized, undermining disease surveillance and early warning. Without decisive action, Africa CDC projects the continent could reverse two decades of health progress, face 2 to 4 million additional preventable deaths annually, and a heightened risk of a pandemic emerging from within. Furthermore, 39 million more Africans could be pushed into poverty by 2030 due to intertwined health and economic shocks. This is not just a sectoral crisis—it is an existential threat to Africa’s political, social, and economic resilience, and global stability. In response, African leaders, under Africa CDC’s stewardship, are advancing a comprehensive three-pillar strategy centered on domestic resource mobilization, innovative financing, and blended finance. more

External Link

Evolution and effectiveness of bilateral and multilateral development assistance for health: a mixed-methods review of trends and strategic shifts (1990–2022)

Xie S., Du S., Huang Y., et al. BMJ Global Health (2025) CC

Development assistance for health (DAH) plays a vital role in supporting health programmes in lowand middle-income countries. While DAH has historically focused on infectious diseases and maternal and child health, there is a lack of comprehensive analysis of DAH trends, strategic shifts and the... more

Download (356)

View PDF (406)

Guidelines for the Structure of Public Health Entomology Laboratories

Pan American Health Organization (PAHO) (2019) C_WHO

This document provides countries with recommendations for structuring a public health entomology laboratory network. The document will help countries to identify their areas of need and determine how the entomology network can be strengthened, especially in the context of a decentralized health syst... more

2019 Antibacterial agents in clinical development: an analysis of the antibacterial clinical development pipeline recommended

2019 Antibacterial agents in clinical development: an analysis of the antibacterial clinical development pipeline
recommended